Single-cell metabolic profiling reveals subgroups of primary human hepatocytes showing heterogeneous responses to drug challenge

Authors:
E. Sanchez-Quant, M. L. Richter, M. Colomé-Tatché , C.P. Martinez-Jimenez
In:
Source: BioResearch Open Access
Publication Date: (2020)
Issue: 0: 0
Research Area:
Toxicology
Drug Discovery
Cells used in publication:
Hepatocyte, human
Species: human
Tissue Origin: liver
Experiment

Each cryovial of PHH was thawed and plated according to Lonza’s “Suspension and plateable cryopreserved hepatocytes: technical information and instructions.”. the protocol was followed stepwise minutely, using the recommended thawing and plating media (Lonza, MCHT50 and MP250, respectively). The cells were dispensed and mixed using only wide orifice tips (Rainin, Ref. 17014297). For efficient cell seeding densities and attachment, cells were counted using  Trypan Blue Exclusion Method and seeded into Collagen-I coated plates at a density of approximately 100,000 cells/cm2 following the Lonza’s instructions (Lonza, “Suspension and Plateable Cryopreserved Hepatocytes Technical Information and Instructions”). Six hours post seeding, cells were washed with 1 mL of pre-warmed Maintenance Medium (Lonza, MCHT50) before addition of treatment media. The treatment medium was renewed every 24h for a total incubation period of 72h post-seeding. Free fatty acids (FFA) consisting of a 200 µM mixture of a 2:1 ratio of the unsaturated oleic acid to the saturated palmitic acid were added to the maintenance media, to mimic the levels in human steatosis (Gómez-Lechón et al. 2007). In order to facilitate FFA uptake, pre-bounding of free fatty acids to 1% bovine serum albumin in a 1:5 molar ratio (Sigma-Aldrich) was performed by heating the mixture at 40ºC for 2 hours (Kozyra et al. Sci Rep 2018).

Abstract

Xenobiotics are primarily metabolized by hepatocytes in the liver, and primary human hepatocytes (PHHs) are the gold standard model for the assessment of drug efficacy, safety and toxicity in the early phases of drug development. Recent advances in single-cell genomics have shown liver zonation and ploidy as main drivers of cellular heterogeneity. However, little is known about the impact of hepatocyte specialization on liver function upon metabolic 60 challenge, including hepatic metabolism, detoxification, and protein synthesis. Here, we investigate the metabolic capacity of individual human hepatocytes in vitro, and assess how chronic accumulation of lipids enhances cellular heterogeneity and impairs the metabolisms of drugs. A phenotyping five-probe cocktail was used to identify four functional subgroups of hepatocytes that respond differently to drug challenge and fatty acid accumulation. These four 65 subgroups display differential gene expression profiles upon cocktail treatment and xenobiotic metabolism-related specialization. Notably, intracellular fat accumulation leads to increased transcriptional variability and diminished the drug-related metabolic capacity of hepatocytes. Our results demonstrate that, upon a metabolic challenge such as exposure to drugs or intracellular fat accumulation, hepatocyte subgroups lead to different and heterogeneous 70 transcriptional responses.